Singapore markets closed
  • Straits Times Index

    3,098.25
    +56.96 (+1.87%)
     
  • S&P 500

    4,567.00
    -88.27 (-1.90%)
     
  • Dow

    34,483.72
    -652.22 (-1.86%)
     
  • Nasdaq

    15,537.69
    -245.14 (-1.55%)
     
  • BTC-USD

    57,205.31
    +478.68 (+0.84%)
     
  • CMC Crypto 200

    1,475.17
    +32.39 (+2.25%)
     
  • FTSE 100

    7,156.07
    +96.62 (+1.37%)
     
  • Gold

    1,784.10
    +7.60 (+0.43%)
     
  • Crude Oil

    69.18
    +3.00 (+4.53%)
     
  • 10-Yr Bond

    1.4430
    0.0000 (0.00%)
     
  • Nikkei

    27,935.62
    +113.86 (+0.41%)
     
  • Hang Seng

    23,658.92
    +183.66 (+0.78%)
     
  • FTSE Bursa Malaysia

    1,496.93
    -17.05 (-1.13%)
     
  • Jakarta Composite Index

    6,507.68
    -26.26 (-0.40%)
     
  • PSE Index

    6,947.06
    -253.82 (-3.52%)
     

This Popular Stock Has a 93% Upside, According to Wall Street

·5-min read
This Popular Stock Has a 93% Upside, According to Wall Street
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

If you had invested in Novavax (NASDAQ: NVAX) at the beginning of 2020, you'd be sitting pretty right now. Novavax's efforts to develop and market a vaccine for COVID-19 explain the company's terrific performance of late. The company's average price target of $264.20 implies gains of 93% from its share price of $136.86 as of this writing.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting